QA: Dermata Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001853816_2025_Dermata_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001853816, Dermata Therapeutics Inc

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 3,533,888
4 LiabilitiesCurrent 808,011
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,164,783
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,309,551
9 ResearchAndDevelopmentExpense 8,203,691
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 225,781
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 3,533,888
1 Liabilities 1,972,794
2 Expenses 12,513,242
3 Revenues 0
4 StockholdersEquity 1,561,094
5 NetIncome -12,287,461
6 ComprehensiveNetIncome -12,287,461
7 BaseVar 9,122,852
8 EconomicCapitalRatiobeforeLimitedLiability -3.23
9 EconomicCapitalRatio 0.613

Edgar->Model Mapping

Feature Distribution

Change over Time